Doxycycline in Cutaneous Schwannoma (NF2)
Condition(s):Neurofibromatosis Type 2Last Updated:October 19, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Neurofibromatosis Type 2Last Updated:October 19, 2023Recruiting
Condition(s):Primary Systemic AmyloidosisLast Updated:July 9, 2021Completed
Condition(s):Resectable Pancreatic CancerLast Updated:July 3, 2023Completed
Condition(s):ST Elevation Myocardial Infarction; Anterior Wall Myocardial Infarction; Heart Failure; Remodeling, VentricularLast Updated:August 6, 2019Unknown status
Condition(s):Thyroid Associated OphthalmopathyLast Updated:November 22, 2023Recruiting
Condition(s):Lymphedema; Lymphatic Filariasis; FilariasisLast Updated:June 24, 2021Completed
Condition(s):Lymphedema; Lymphatic Filariasis; FilariasisLast Updated:March 17, 2021Completed
Condition(s):Cutaneous T-cell Lymphoma; Mycosis Fungoides; Sezary SyndromeLast Updated:April 27, 2021Terminated
Condition(s):Lymphedema; Lymphatic Filariasis; FilariasisLast Updated:June 24, 2021Completed
Condition(s):Vascular Diseases; Cardiovascular Diseases; Acute Myocardial InfarctionLast Updated:December 13, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.